Vishwani S. Jamwal - Publications

Characterization of beddomeilactone amide as bacterial DNA gyrase inhibitor: in vitro evaluation and computational insights.

Journal: Medicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents

Published: June 22, 2026

N-sulfonylated indole hydrazone hybrid targeting Staphylococcus aureus with compelling antibiofilm and membrane-disrupting properties.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: April 27, 2026

Synthesis-guided design and discovery of alkylated indoles with antibacterial activity against MRSA.

Journal: RSC medicinal chemistry

Published: March 19, 2026

Targeting methicillin-susceptible and -resistant Staphylococcus aureus: Design, synthesis, and antibacterial profiling of novel beddomeilactone amides.

Journal: Bioorganic chemistry

Published: December 09, 2025

Novel isatin-chalcone molecular hybrids endowed with potent antistaphylococcal properties: In vitro and mechanistic insights.

Journal: Bioorganic chemistry

Published: October 23, 2025

Deciphering mechanistic and therapeutic insight of pyrazolopyrimidines into MRSA suppression: comprehensive in vitro and in vivo study.

Journal: Bioorganic chemistry

Published: October 13, 2025

Extract engineering of Cannabis sativa yields novel antibacterial cannabinoids targeting Staphylococcus aureus and methicillin-resistant Staphylococcus aureus.

Journal: Bioorganic chemistry

Published: September 25, 2025

Harnessing biological insights to accelerate drug discovery against ESKAPE pathogens.

Journal: RSC medicinal chemistry

Published: April 24, 2025

High-throughput screening identifies novel chemical scaffolds targeting Leishmania donovani parasites.

Journal: World journal of microbiology & biotechnology

Published: March 21, 2025

Breaking the resistance: integrative approaches with novel therapeutics against Klebsiella pneumoniae.

Journal: Archives of microbiology

Published: September 12, 2024

Understanding the mechanisms of antimicrobial resistance and potential therapeutic approaches against the Gram-negative pathogen Acinetobacter baumannii.

Journal: RSC medicinal chemistry

Published: June 18, 2024

Repurposing FDA approved drugs against Sterol C-24 methyltransferase of Leishmania donovani: A dual in silico and in vitro approach.

Journal: Acta tropica

Published: May 12, 2024